{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Steroid 16-alpha-hydroxylase : Questions médicales les plus fréquentes",
"headline": "Steroid 16-alpha-hydroxylase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Steroid 16-alpha-hydroxylase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Steroid 16-alpha-hydroxylase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Steroid hydroxylases",
"url": "https://questionsmedicales.fr/mesh/D013250",
"about": {
"@type": "MedicalCondition",
"name": "Steroid hydroxylases",
"code": {
"@type": "MedicalCode",
"code": "D013250",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.915"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Steroid 16-alpha-hydroxylase",
"alternateName": "Steroid 16-alpha-Hydroxylase",
"code": {
"@type": "MedicalCode",
"code": "D039181",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ki-Hwa Kim",
"url": "https://questionsmedicales.fr/author/Ki-Hwa%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Tae-Jin Oh",
"url": "https://questionsmedicales.fr/author/Tae-Jin%20Oh",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Chang Woo Lee",
"url": "https://questionsmedicales.fr/author/Chang%20Woo%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Research Unit of Cryogenic Novel Materials, Korea Polar Research Institute, Incheon 21990, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Pradeep Subedi",
"url": "https://questionsmedicales.fr/author/Pradeep%20Subedi",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Case report: Co-occurring obsessive-compulsive disorder and affective psychotic disorder complicated by catatonia in an adolescent female patient.",
"datePublished": "2023-10-12",
"url": "https://questionsmedicales.fr/article/37900288",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpsyt.2023.1225827"
}
},
{
"@type": "ScholarlyArticle",
"name": "The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders: a National registry study.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/37821976",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13722-023-00415-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) and Oppositional Defiant Disorder (ODD) on Academic Performance and Educational Attainment.",
"datePublished": "2023-09-01",
"url": "https://questionsmedicales.fr/article/37658240",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10578-023-01598-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021).",
"datePublished": "2023-08-25",
"url": "https://questionsmedicales.fr/article/37624975",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/npr2.12365"
}
},
{
"@type": "ScholarlyArticle",
"name": "Personality functioning and self-disorders in individuals at ultra-high risk for psychosis, with first-episode psychosis and with borderline personality disorder.",
"datePublished": "2023-08-11",
"url": "https://questionsmedicales.fr/article/37563768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/bjo.2023.530"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hémoprotéines",
"item": "https://questionsmedicales.fr/mesh/D006420"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytochromes",
"item": "https://questionsmedicales.fr/mesh/D003580"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cytochrome P-450 enzyme system",
"item": "https://questionsmedicales.fr/mesh/D003577"
},
{
"@type": "ListItem",
"position": 7,
"name": "Steroid hydroxylases",
"item": "https://questionsmedicales.fr/mesh/D013250"
},
{
"@type": "ListItem",
"position": 8,
"name": "Steroid 16-alpha-hydroxylase",
"item": "https://questionsmedicales.fr/mesh/D039181"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Steroid 16-alpha-hydroxylase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Steroid 16-alpha-hydroxylase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Steroid 16-alpha-hydroxylase",
"description": "Comment diagnostiquer une déficience en 16-alpha-hydroxylase ?\nQuels tests génétiques sont utilisés pour cette enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nQuel rôle joue l'imagerie dans le diagnostic ?\nLes tests de fonction hépatique sont-ils pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Language+Development+Disorders&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Steroid 16-alpha-hydroxylase",
"description": "Quels sont les symptômes d'une surproduction d'androgènes ?\nComment se manifeste une insuffisance en stéroïdes ?\nLes symptômes varient-ils selon le sexe ?\nY a-t-il des symptômes associés à des troubles métaboliques ?\nLes symptômes peuvent-ils apparaître à l'adolescence ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Language+Development+Disorders&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Steroid 16-alpha-hydroxylase",
"description": "Peut-on prévenir les troubles liés à cette enzyme ?\nY a-t-il des tests de dépistage recommandés ?\nComment l'éducation peut-elle aider à la prévention ?\nLes habitudes alimentaires influencent-elles la santé hormonale ?\nLe stress a-t-il un impact sur cette enzyme ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Language+Development+Disorders&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Steroid 16-alpha-hydroxylase",
"description": "Quels traitements sont disponibles pour les déséquilibres hormonaux ?\nLes médicaments peuvent-ils aider à réguler cette enzyme ?\nY a-t-il des traitements non médicamenteux ?\nComment la chirurgie peut-elle être impliquée ?\nLes traitements sont-ils différents pour les hommes et les femmes ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Language+Development+Disorders&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Steroid 16-alpha-hydroxylase",
"description": "Quelles complications peuvent survenir avec un déséquilibre hormonal ?\nLes troubles psychologiques sont-ils liés à cette enzyme ?\nY a-t-il des risques de cancer associés ?\nComment les maladies métaboliques sont-elles liées ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Language+Development+Disorders&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Steroid 16-alpha-hydroxylase",
"description": "Quels facteurs de risque sont associés à des troubles hormonaux ?\nL'âge influence-t-il le risque de déséquilibre hormonal ?\nLes médicaments peuvent-ils affecter cette enzyme ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes facteurs environnementaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Language+Development+Disorders&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en 16-alpha-hydroxylase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins pour mesurer les niveaux d'hormones stéroïdiennes sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés pour cette enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses génétiques ciblent les mutations dans le gène CYP3A4."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'hyperandrogénie ou des irrégularités menstruelles peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à évaluer les glandes endocrines, mais n'est pas spécifique."
}
},
{
"@type": "Question",
"name": "Les tests de fonction hépatique sont-ils pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, car le foie est crucial pour le métabolisme des stéroïdes et peut indiquer des anomalies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surproduction d'androgènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Acné, hirsutisme, irrégularités menstruelles et infertilité peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une insuffisance en stéroïdes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, perte de poids, hypotension et dépression peuvent être des signes d'insuffisance."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le sexe ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes et les femmes peuvent présenter des symptômes différents en raison des hormones."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à des troubles métaboliques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme le diabète peuvent être liés à des anomalies hormonales."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils apparaître à l'adolescence ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements hormonaux peuvent se manifester durant la puberté."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés à cette enzyme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière et un mode de vie sain peuvent aider à prévenir certains troubles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests de dépistage recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests hormonaux réguliers peuvent être recommandés pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "Comment l'éducation peut-elle aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sur les symptômes et les risques peut aider à une détection précoce."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la santé hormonale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir la santé hormonale et prévenir des déséquilibres."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur cette enzyme ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la production hormonale et aggraver les symptômes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les déséquilibres hormonaux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies hormonales substitutives peuvent être prescrites pour rétablir l'équilibre."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à réguler cette enzyme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains inhibiteurs enzymatiques peuvent être utilisés pour moduler l'activité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de mode de vie, comme l'alimentation et l'exercice, peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment la chirurgie peut-elle être impliquée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, une intervention chirurgicale peut être nécessaire pour corriger des anomalies."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les hommes et les femmes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des besoins hormonaux spécifiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un déséquilibre hormonal ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'infertilité, le diabète et des maladies cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles psychologiques sont-ils liés à cette enzyme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme l'anxiété et la dépression peuvent être exacerbés par des déséquilibres."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les déséquilibres hormonaux et le cancer hormonal."
}
},
{
"@type": "Question",
"name": "Comment les maladies métaboliques sont-elles liées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déséquilibres hormonaux peuvent contribuer à des maladies métaboliques comme le diabète."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et précoce."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à des troubles hormonaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux, l'obésité et le stress sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de déséquilibre hormonal ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout pendant la ménopause chez les femmes."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils affecter cette enzyme ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec l'activité de la stéroïde 16-alpha-hydroxylase."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains produits chimiques peut affecter la fonction hormonale."
}
}
]
}
]
}
We present the case of a 16-year-old female patient who experienced the loss of her mother to suicide, leading to post-traumatic stress disorder and prominent mood symptoms. She developed catatonic fe...
The time after contact with specialized health services for mental health and substance use is associated with an increased risk of suicide, where temporal aspects of suicide and comorbid mental disor...
This study is a historical prospective case series using nationwide registry data. It included 946 individuals registered the year before suicide with a substance use disorder (F10-F19) in Norway's sp...
The number of weeks from last service contact to suicide differed (p = < 0.001) between patients with no comorbid mental disorders (Median = 7; IQR 2-23), psychosis or bipolar disorders (Median = 2; I...
While patients with substance use disorders generally died by suicide a short time after contact with services, patients with comorbid mental disorders died an even shorter time after such contact and...
The aim of this longitudinal population-based cohort study was to examine the effects of ADHD and ODD symptoms in adolescence on academic performance at age 16, and on educational attainment by the ag...
The development of clinical practice guidelines for social anxiety disorder began in March 2018 when the Joint Clinical Practice Guideline Development Committee for Anxiety and Obsessive-Compulsive Di...
Assessment of personality functioning in different stages of psychotic disorders could provide valuable information on psychopathology, course of illness and treatment planning, but empirical data are...
To investigate personality functioning and sense of self in individuals at ultra-high risk (UHR) for psychosis and with first-episode psychosis (FEP) in comparison with a clinical control group of ind...
In a cross-sectional design, we investigated personality functioning (Structured Interview of Personality Organization, STIPO; Level of Personality Functioning Scale, LPFS) and disturbances of the bas...
The UHR, FEP and BPD groups had moderate to severe deficits in personality organisation (STIPO) compared with the healthy control group. Self-functioning with its subdomain (facet) 'self-direction' (L...
Our data demonstrate that psychotic disorders are associated with impaired personality functioning and self-disturbances. Assessment of personality functioning can inform treatment planning for patien...
It is known that patients reporting chronic pain often experience trauma or post-traumatic stress disorder (PTSD) and tend to be more difficult to treat. Attention deficit hyperactivity disorder (ADHD...
In this study, we reported a case where ATX improved chronic pain with PTSD and improved cerebral blood flow. The patient was a 56-year-old woman exhibiting chronic pain with PTSD, resulting from 6 ye...
The study showed that chronic pain with PTSD may be comorbid with ADHD. Moreover, we found that ATX can improve chronic pain with PTSD and cerebral blood flow. Aggressive screening of ADHD is importan...
Adapt and test a measure of knowledge for caregivers of children with attention-deficit/hyperactivity disorder (ADHD) and evaluate the impact of the information component of a decision aid (DA) on par...
A set of seven knowledge items were created based on prior knowledge measures and clinical guidelines. As part of a larger cross-sectional survey study of caregivers of children diagnosed with ADHD, c...
Caregivers were assigned to the DA arm (n = 243) or the control arm (n = 260). All 7 knowledge items were retained as no items were too difficult or too easy, all response options were used, there wer...
The Caregiver ADHD Knowledge (CAKe) measure was acceptable and demonstrated construct validity as those who were assigned to review the DA component demonstrated greater knowledge than those who were ...
Depression is one of the early and most persistent non-motor symptoms of Parkinson's disease (PD), which remains ignored, resulting in the underdiagnosis of PD. Unfortunately, scarce studies and the n...
This fictionalized case report captures the common themes and considerations during the diagnostic assessment and behavioral treatment of adolescents demonstrating symptoms of autism spectrum disorder...
In schizophrenia spectrum disorders (SSD), social cognition mediates the relationship between neurocognition and social functioning. Although people with major depressive disorder (MDD) also exhibit c...
Using data obtained through an internet survey, 210 patients with SSD or MDD were selected using propensity score matching based on their demographics and illness duration. Social cognition, neurocogn...
The SSD and MDD groups had mean ages of 44.49 and 45.35 years, contained 42.0% and 42.8% women, and had mean illness durations of 10.76 and 10.45 years, respectively. In both groups, social cognition ...
The role of social cognition in patients with MDD was similar to that in SSD. Social cognition could be a common endophenotype for various psychiatric disorders....